You have 9 free searches left this month | for more free features.

Exenatide

Showing 26 - 50 of 425

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type2 Diabetes Trial in Evansville (Bexagliflozin, Exenatide Injection)

Completed
  • Type2 Diabetes Mellitus
  • Evansville, Indiana
    Clinical Research Site
May 5, 2021

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Recruiting
  • Type 2 Diabetes Mellitus
  • Cardiovascular Diseases
  • Oakland, California
  • +5 more
Oct 18, 2022

Cerebral Small Vessel Disease Trial in Hong Kong (Exenatide extended release)

Recruiting
  • Cerebral Small Vessel Disease
  • Exenatide extended release
  • Hong Kong, Hong Kong
    Chinese University of Hong Kong
Jul 18, 2022

Acute Ischemic Stroke Trial in Australia, Finland, New Zealand (Exenatide Injection)

Active, not recruiting
  • Acute Ischemic Stroke
  • Exenatide Injection
  • Darlinghurst, New South Wales, Australia
  • +14 more
Sep 7, 2021

Obesity Trial in Salzburg, Uppsala (Exenatide, Placebo)

Completed
  • Obesity
  • Exenatide
  • Placebo
  • Salzburg, Austria
  • +1 more
May 17, 2022

Type 2 Diabetes, Obesity Trial in Cambridge (0.9% Sodium-chloride, Exenatide (50ng/min for 30 minutes loading followed by

Recruiting
  • Type 2 Diabetes
  • Obesity
  • 0.9% Sodium-chloride
  • +3 more
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust and The Univ
Jan 18, 2022

Type 2 Diabetes, Obesity Trial in Amsterdam (Dapagliflozin 10mg, Exenatide, exenatide)

Completed
  • Type 2 Diabetes Mellitus
  • Obesity
  • Dapagliflozin 10mg
  • +3 more
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VU Medical Center
Jun 8, 2021

Obesity Trial in Changsha (Liraglutide, Exenatide, Exenatide Microspheres for Injection)

Recruiting
  • Obesity
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Apr 7, 2021

Quality of Life Trial in Besançon (Exenatide, Insulin)

Completed
  • Quality of Life
  • Besançon, France
    Post operative intensive care unit of the cardiac surgery depart
Mar 5, 2021

Smoking Cessation Trial in Houston (Exenatide, NRT, Counseling)

Completed
  • Smoking Cessation
  • Exenatide
  • +3 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jan 26, 2021

Cardiovascular Diseases Trial in Cambridge (Saline 0.9%, Glucagon (25ng/kg/min), Glucagon (50ng/kg/min))

Recruiting
  • Cardiovascular Diseases
  • Saline 0.9%
  • +3 more
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Dec 10, 2021

Children and Adolescent With Type 2 Diabetes Trial in Worldwide (Exenatide Once Weekly, Placebo)

Completed
  • Children and Adolescent With Type 2 Diabetes
  • Exenatide Once Weekly
  • Placebo
  • Los Angeles, California
  • +34 more
Nov 2, 2021

Childhood Obesity Trial in Seattle (Family Based Behavioral Treatment, Exenatide 2 mg [Bydureon], Placebo)

Recruiting
  • Childhood Obesity
  • Family Based Behavioral Treatment
  • +2 more
  • Seattle, Washington
    Seattle Children's Hospital
Aug 30, 2021

Severe Obesity Trial in Minneapolis (Weight loss with pharmacotherapy, Weight loss without pharmacotherapy)

Completed
  • Severe Obesity
  • Weight loss with pharmacotherapy
  • Weight loss without pharmacotherapy
  • Minneapolis, Minnesota
    University of Minnesota
Dec 1, 2021

Atherosclerosis, Diabetes, Restenosis Trial in Stockholm (Bydureon, Humulin kwickpen, Metformin)

Recruiting
  • Atherosclerosis
  • +2 more
  • Stockholm, Other, Sweden
    Dept of clinical science and education Karolinska Institutet Söd
Aug 31, 2021

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Early Parkinson's Disease Trial in Seongnam-si, Seoul (PT320 2.0mg Placebo, PT320 2.0 mg, PT320 2.5 mg)

Active, not recruiting
  • Early Parkinson's Disease
  • PT320 2.0mg Placebo
  • +2 more
  • Seongnam-si, Korea, Republic of
  • +4 more
Apr 7, 2021

Diabetes Trial in Boston (Albiglutide 50mg, Albiglutide matching , Exenatide 10microgram)

Terminated
  • Diabetes Mellitus
  • Albiglutide 50mg
  • +3 more
  • Boston, Massachusetts
    GSK Investigational Site
Oct 8, 2020

Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism Trial in Barcelona (Experimental: GLP1-RA (exenatide)

Recruiting
  • Hypopituitarism
  • +7 more
  • Experimental: GLP1-RA (exenatide) administration
  • Control: Placebo administration
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Mar 18, 2022

Ischemic Stroke Trial in Herlev (Byetta, Normosaline)

Recruiting
  • Ischemic Stroke
  • Herlev, Denmark
    Department of Neurology, Herlev-Gentofte Hospital
Nov 13, 2021

Type 2 Diabetes, Chronic Kidney Disease, Left Ventricular Diastolic Dysfunction Trial in Dallas (BYDUREON, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • +2 more
  • Dallas, Texas
    Baylor Scott and White Research Institute- Baylor Heart and Vasc
Jan 25, 2021

Diabetes, Type 2 Trial in Louisville, Dallas (Exenatide, Albiglutide)

Terminated
  • Diabetes Mellitus, Type 2
  • Louisville, Kentucky
  • +1 more
Oct 8, 2020

Type 2 Diabetes, Incretinomimetics, Pancreas Trial in Brussels (Incretinomimetics, DPP-4 inhibitors)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Brussels, Belgium
    Gastroenterology Department Erasme Hospital
Mar 1, 2021

Multiple System Atrophy Trial in London (Exenatide Pen Injector [Bydureon])

Recruiting
  • Multiple System Atrophy
  • Exenatide Pen Injector [Bydureon]
  • London, United Kingdom
    Leonard Wolfson Experimental Neurology Centre, National Hospital
Nov 4, 2020

Cocaine Dependence Trial in New Haven (cocaine HCl, exenatide, )

Completed
  • Cocaine Dependence
  • cocaine hydrochloride
  • +2 more
  • New Haven, Connecticut
    Connecticut Mental Health Center
Feb 25, 2021